HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nikos K Karamanos Selected Research

Carcinogenesis

1/2020Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.
1/2019Proteoglycans remodeling in cancer: Underlying molecular mechanisms.
1/2017Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
4/2014Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response.
2/2013Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells.
1/2011Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nikos K Karamanos Research Topics

Disease

73Neoplasms (Cancer)
04/2024 - 09/2002
36Breast Neoplasms (Breast Cancer)
08/2022 - 09/2002
14Neoplasm Metastasis (Metastasis)
04/2024 - 01/2008
8Inflammation (Inflammations)
03/2024 - 01/2014
6Triple Negative Breast Neoplasms
08/2022 - 05/2020
6Carcinogenesis
01/2020 - 01/2011
6Colonic Neoplasms (Colon Cancer)
01/2015 - 12/2007
6Osteosarcoma (Osteogenic Sarcoma)
10/2011 - 01/2003
4Pathologic Processes
01/2019 - 01/2010
4Carcinoma (Carcinomatosis)
01/2019 - 07/2011
4Lung Neoplasms (Lung Cancer)
01/2016 - 10/2009
4Fibrosarcoma
02/2013 - 10/2009
3Fibrosis (Cirrhosis)
03/2024 - 01/2018
3Disease Progression
01/2020 - 01/2015
3Melanoma (Melanoma, Malignant)
12/2011 - 06/2009
3Atherosclerosis
01/2010 - 07/2002
2Squamous Cell Carcinoma of Head and Neck
04/2024 - 07/2006
2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 02/2016
2Infections
11/2015 - 05/2012
2Colorectal Neoplasms (Colorectal Cancer)
08/2014 - 12/2007
2Seminoma
08/2014 - 01/2013
2Multiple Myeloma
05/2013 - 11/2006
2Vascular Diseases (Vascular Disease)
12/2002 - 07/2002
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Glioma (Gliomas)
01/2021

Drug/Important Bio-Agent (IBA)

24Proteoglycans (Proteoglycan)IBA
01/2022 - 09/2002
17Hyaluronic Acid (Hyaluronan)IBA
10/2022 - 01/2010
17Estrogen ReceptorsIBA
01/2022 - 09/2002
12GlycosaminoglycansIBA
12/2021 - 09/2002
11EnzymesIBA
03/2024 - 12/2007
10Biomarkers (Surrogate Marker)IBA
04/2024 - 10/2010
10Matrix Metalloproteinases (MMPs)IBA
01/2020 - 11/2006
7SyndecansIBA
03/2024 - 11/2002
7Fibronectins (Fibronectin)IBA
05/2020 - 02/2011
7serglycinIBA
05/2020 - 11/2006
7Protein Isoforms (Isoforms)IBA
12/2017 - 10/2009
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2024 - 06/2009
6DecorinIBA
03/2024 - 12/2002
6Hormones (Hormone)IBA
01/2020 - 05/2013
5BiglycanIBA
03/2024 - 12/2002
5MicroRNAs (MicroRNA)IBA
01/2023 - 12/2017
5Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2010
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 05/2013
5Estrogens (Estrogen)FDA Link
05/2020 - 10/2008
5Versicans (Versican)IBA
07/2011 - 11/2002
5Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2010 - 07/2002
4CytokinesIBA
04/2024 - 01/2014
4Messenger RNA (mRNA)IBA
01/2022 - 11/2002
4Peptide Hydrolases (Proteases)FDA Link
03/2021 - 10/2010
4Estradiol (Delestrogen)FDA LinkGeneric
12/2017 - 10/2008
4CollagenIBA
12/2016 - 05/2008
4Epidermal Growth Factor (EGF)IBA
12/2016 - 05/2008
4LumicanIBA
04/2014 - 01/2008
4Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2013 - 06/2009
3Heparin (Liquaemin)FDA LinkGeneric
03/2024 - 05/2008
3Small Interfering RNA (siRNA)IBA
01/2022 - 06/2009
3Complement System Proteins (Complement)IBA
01/2021 - 01/2013
3Collagen Type I (Type I Collagen)IBA
10/2020 - 01/2005
3Phosphotransferases (Kinase)IBA
05/2020 - 11/2002
3Estrogen Receptor alphaIBA
12/2017 - 10/2008
3Insulin-Like Growth Factor I (IGF-1)IBA
12/2016 - 04/2004
3Heparitin Sulfate (Heparan Sulfate)IBA
10/2015 - 05/2008
3Imatinib Mesylate (Gleevec)FDA Link
05/2013 - 12/2007
3Syndecan-2IBA
05/2013 - 10/2008
3GlypicansIBA
05/2013 - 10/2010
3Syndecan-4IBA
05/2013 - 06/2009
3Peptides (Polypeptides)IBA
05/2010 - 12/2005
3Tyrosine Kinase InhibitorsIBA
01/2008 - 11/2002
3GenisteinIBA
04/2004 - 09/2002
2LigandsIBA
03/2024 - 05/2008
2Transcription Factors (Transcription Factor)IBA
04/2023 - 04/2014
2LeptinIBA
08/2022 - 01/2005
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 05/2008
2Interleukin-8 (Interleukin 8)IBA
12/2018 - 11/2015
2ChemokinesIBA
12/2018 - 01/2014
2Estrogen Receptor betaIBA
12/2017 - 12/2016
2heparanaseIBA
01/2017 - 01/2014
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2016 - 11/2002
2Syndecan-1 (Syndecan 1)IBA
01/2016 - 10/2015
2Platelet-Derived Growth FactorIBA
01/2014 - 05/2013
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2014 - 05/2013
2Becaplermin (PDGF-BB)FDA Link
05/2013 - 01/2013
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
05/2013 - 05/2013
2AerosolsIBA
04/2013 - 01/2012
2Parathyroid Hormone (Parathormone)IBA
10/2011 - 05/2010
2Small Leucine-Rich ProteoglycansIBA
06/2011 - 01/2008
2perlecanIBA
10/2010 - 11/2002
2Dermatan SulfateIBA
01/2010 - 07/2002
2ChondroitinIBA
05/2008 - 07/2002
2Metalloproteases (Metalloproteinases)IBA
01/2008 - 11/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2004 - 01/2003
2IsoflavonesIBA
01/2003 - 09/2002
1gag Gene Products (gag Protein)IBA
03/2024
1ResistinIBA
08/2022
1AdiponectinIBA
08/2022
1AdipokinesIBA
08/2022
1FR 190997IBA
01/2021

Therapy/Procedure

10Therapeutics
04/2023 - 10/2009
4Drug Therapy (Chemotherapy)
01/2022 - 09/2012
1Precision Medicine
10/2022